Moreover, PRAME expression has also been reported in various types of malignant tumor, other than malignant melanoma, including myxoid liposarcoma, synovial sarcoma, neuroblastoma, renal cell carcinoma, non-small-cell lung cancer, and thymic cancer [8,13,14,25,26,27,28,29,30]. Here, PRAME is linked to non-small cell lung carcinoma.